Rotella Capital Management, Inc. - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 43 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$64,000
+156.0%
10,428
-32.8%
0.02%
-4.5%
Q4 2014$25,000
-72.2%
15,528
-41.4%
0.02%
-71.1%
Q2 2014$90,000
+23.3%
26,514
+21.1%
0.08%
-14.6%
Q1 2014$73,00021,9020.09%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sio Capital Management, LLC 2,535,564$7,835,0004.00%
ProQuest Associates IV LLC 1,900,000$5,871,0002.39%
Abingworth LLP 437,994$1,349,0001.41%
Hilltop Park Associates LLC 75,000$232,0000.97%
Broadfin Capital, LLC 1,154,674$3,568,0000.35%
Perceptive Advisors 1,492,156$4,611,0000.32%
Rhenman & Partners Asset Management AB 300,000$927,0000.16%
Rock Springs Capital Management LP 450,000$1,391,0000.10%
WEXFORD CAPITAL LP 145,622$450,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 15,960$49,0000.02%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders